Pharmaceuticals

Relaxing the tension between Publishing and Patenting: The Legal Basis for Tension – Part One In the summer of 1975, at a Medical Research Council (MRC) meeting, a presentation was given by scientists César Milstein and Georges Köhler.1 The topic: monoclonal antibodies. The presentation was attended by Tony Vickers, a member of the MRC, who… Read more »

Patent Attorneys Geoff Hussey, Craig Turner, Alex Bone and Leonita Paulraj are attending CPhI’s 7th Annual Pharma IPR Conference in Mumbai, India from 7th-9th March. Craig and Geoff will also be speaking about the implications of Brexit on Indian pharma companies on the 8th March. CPhI’s 7th Annual Pharma IPR Conference is a leading platform… Read more »

Trade Mark Partner Rachel Havard and Consulting Patent Attorney Julie Barrett Major will represent the firm at the Spring Pharmaceutical Trade Marks Group conference in Porto, Portugal from 18th – 20th March. PTMG is a not for profit organisation and their primary objective is to enable members to meet at regular intervals to consider problems… Read more »

Consulting Patent Attorney Julie Barrett-Major and Trainee Patent Attorney Lucy O’Brien will attend the 12th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry on 26th and 27th of February 2018 in London. ‘The conference is a specially organized two day event which will provide a multi-channel communication platform that brings together both “producers”… Read more »

Recent governmental report on the UK Life Sciences Sector A report (The Bell Report) to the UK government[1] has recently published, with the aim of bringing into focus the next 20 years of UK government policy in the ‘health life sciences’ sector. In the context of the report, ‘health life sciences’ refers to the application… Read more »

In response to an opposition by chemicals company BASF, Craig Turner, a partner in our Chemistry, Biotechnology and Pharmaceutical patents team, successfully defended Lycored’s European patent which protects their unique lycopene formulation, used for providing stable red colouring for foods, cosmetics and pharmaceuticals. Longstanding client Lycored are a market-leader in the development and supply of research-based,… Read more »

Background Napp Pharmaceuticals (Napp) is the proprietor of a European (UK) patent, EP2305194B (the Patent), which provides protection for transdermal buprenorphine patches. Napp have marketed buprenorphine patches under the trade name “BuTrans®” since 2005. Both Sandoz and Dr Reddy’s were preparing to launch generic transdermal buprenorphine patches in the UK, but Sandoz were the first… Read more »

From 1 April 2013 onwards, the cost of patenting will be outweighed by patent-related tax savings for many UK companies.

Christopher Burnett, Patent Attorney attended the Global Pharma IP Forum at the London Stock Exchange on 28 September.